Meeting
2020 ASCO Virtual Scientific Program
Antiemetic prophylaxis with NEPA: Final results of the German AKYPRO study.
Authors
Joerg Peter Schilling
Onkologische Schwerpunktpraxis, Berlin, Germany
Joerg Peter Schilling , Steffi Busch , Carsten Hielscher , Martin Holländer , Julia Klenske , Mark-Oliver Zahn , Meinolf Karthaus
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Palliative Care and Symptom Management
Citation
J Clin Oncol 38: 2020 (suppl; abstr 12095)
DOI
10.1200/JCO.2020.38.15_suppl.12095
Abstract #
12095
Poster Bd #
383
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting (CINV): Results of the Nausea/Emesis Registry in Oncology (NERO).
First Author: Matti S. Aapro
Poster
2019 ASCO Annual Meeting
Physician concordance with update to ASCO guidelines for antiemetic use with carboplatin AUC ≥ 4.
First Author: Rudolph M. Navari
Poster
2017 Palliative and Supportive Care in Oncology Symposium
Comparison of hydration events in patients (pts) receiving highly (HEC) or moderately (MEC) emetogenic chemotherapy treated with granisetron extended-release subcutaneous (GERSC) or palonosetron (PALO).
First Author: Jeffrey Vacirca
Poster
2016 ASCO Annual Meeting
Placebo-controlled phase III study comparing dexamethasone on day 1 to on day 1-3 with NK1 receptor antagonist and palonosetoron in high emetogenic chemotherapy.
First Author: Kunihiro Matsuzaki